CCOC(=O)c1ccccc1NC(=O)Cn1c(=O)n(-c2ccc(CC)cc2)c(=O)c2c(C)c(C(=O)N(C)C)sc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?